Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 8 (August)

1. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
   Lancet Oncol, 6(8): 557-65. [Abstract] [Full-text]
2. Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing.
   Cancer Sci, 96(7): 441-50. [Abstract] [Full-text]
3. Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model.
   J Am Soc Mass Spectrom, 16(8): 1221-30. [Abstract] [Full-text]
4. It's about time: scheduling alters effect of histone deacetylase inhibitors on camptothecin-treated cells.
   Cancer Res, 65(15): 6957-66. [Abstract] [Full-text]
5. Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.
   Cancer Res, 65(15): 6943-9. [Abstract] [Full-text]
6. CD44 attenuates metastatic invasion during breast cancer progression.
   Cancer Res, 65(15): 6755-63. [Abstract] [Full-text]
7. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
   Cancer Res, 65(15): 6576-82. [Abstract] [Full-text]
8. Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.
   Bioorg Med Chem Lett, 15(17): 3948-52. [Abstract] [Full-text]
9. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
   Lung, 183(3): 177-83. [Abstract] [Full-text]
10. Atrial fibrillation complicating lung cancer resection.
    J Thorac Cardiovasc Surg, 130(2): 438-44. [Abstract] [Full-text]
11. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations.
    J Thorac Cardiovasc Surg, 130(2): 433-7. [Abstract] [Full-text]
12. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
    J Thorac Cardiovasc Surg, 130(2): 416-25. [Abstract] [Full-text]
13. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience.
    J Thorac Cardiovasc Surg, 130(2): 408-15. [Abstract] [Full-text]
14. Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates.
    Phys Med Biol, 50(16): 3655-67. [Abstract] [Full-text]
15. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases.
    Hum Gene Ther, 16(8): 937-46. [Abstract] [Full-text]
16. Lung cancer and indoor pollution from heating and cooking with solid fuels: the IARC international multicentre case-control study in Eastern/Central Europe and the United Kingdom.
    Am J Epidemiol, 162(4): 326-33. [Abstract] [Full-text]
17. Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma.
    Int J Cancer, 116(6): 876-84. [Abstract] [Full-text]
18. Tumour biology: senescence in premalignant tumours.
    Nature, 436(7051): 642. [Abstract] [Full-text]
19. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.
    Br J Cancer, 93(3): 355-63. [Abstract] [Full-text]
20. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.
    Clin Exp Metastasis, 22(2): 185-93. [Abstract] [Full-text]
21. Well-differentiated extraosseous chondrosarcoma of the foot with pulmonary metastases.
    Hum Pathol, 36(7): 838-40. [Abstract] [Full-text]
22. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
    Hum Pathol, 36(7): 768-76. [Abstract] [Full-text]
23. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
    Hum Pathol, 36(7): 718-23. [Abstract] [Full-text]
24. Vitamin E succinate decreases lung cancer tumor growth in mice.
    J Surg Res, 127(2): 139-43. [Abstract] [Full-text]
25. A population-based study of lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations.
    Cancer, 104(4): 833-40. [Abstract] [Full-text]
26. Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
    Cancer, 104(4): 811-6. [Abstract] [Full-text]
27. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
    Cancer, 104(4): 817-24. [Abstract] [Full-text]
28. Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2-adrenergic receptor single-nucleotide polymorphisms.
    Genes Chromosomes Cancer, 44(2): 212-7. [Abstract] [Full-text]
29. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Cancer Immunol Immunother, 54(10): 1018-25. [Abstract] [Full-text]
30. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Int J Cancer, 117(1): 51-8. [Abstract] [Full-text]
31. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Int J Cancer, 117(1): 21-31. [Abstract] [Full-text]
32. CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice.
    Cancer Immunol Immunother, 54(10): 944-52. [Abstract] [Full-text]
33. Radiotherapy planning for lung cancer: slow CTs allow the drawing of tighter margins.
    Radiother Oncol, 75(2): 165-70. [Abstract] [Full-text]
34. Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer.
    Radiother Oncol, 75(2): 149-56. [Abstract] [Full-text]
35. Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report.
    APMIS, 113(7): 550-4. [Abstract] [Full-text]
36. Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
    Oncology, 68(2): 223-9. [Abstract] [Full-text]
37. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.
    J Clin Endocrinol Metab, 90(8): 4955-62. [Abstract] [Full-text]
38. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
    Radiother Oncol, 75(2): 157-64. [Abstract] [Full-text]
39. CHART in lung cancer: economic evaluation and incentives for implementation.
    Radiother Oncol, 75(2): 171-8. [Abstract] [Full-text]
40. Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.
    Am J Physiol Lung Cell Mol Physiol, 289(3): L419-28. [Abstract] [Full-text]
41. Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer.
    Am J Physiol Lung Cell Mol Physiol, 289(3): L438-45. [Abstract] [Full-text]
42. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
    Am J Physiol Lung Cell Mol Physiol, 289(3): L446-53. [Abstract] [Full-text]
43. Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence.
    Chest, 128(2): 947-57. [Abstract] [Full-text]
44. Quantitative detection of lung cancer cells by fluorescence in situ hybridization: comparison with conventional cytology.
    Chest, 128(2): 906-11. [Abstract] [Full-text]
45. Transbronchial needle aspiration in the diagnosis of endobronchial malignant lesions: a 3-year experience.
    Chest, 128(2): 704-8. [Abstract] [Full-text]
46. The impact of positron emission tomography on clinical decision making in a university-based multidisciplinary lung cancer practice.
    Chest, 128(2): 698-703. [Abstract] [Full-text]
47. Metastasis gets site specific.
    Cancer Cell, 8(2): 93-5. [Abstract] [Full-text]
48. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis.
    J Biol Chem, 280(33): 29828-36. [Abstract] [Full-text]
49. Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
    Oncology, 68(4): 485-92. [Abstract] [Full-text]
50. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
    Oncology, 68(4): 382-90. [Abstract] [Full-text]
51. Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.
    Oncology, 68(4): 350-5. [Abstract] [Full-text]
52. Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro.
    Cell Biol Int, 29(8): 703-8. [Abstract] [Full-text]
53. Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.
    J Natl Cancer Inst, 97(16): 1185-94. [Abstract] [Full-text]
54. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer.
    Br J Cancer, 93(4): 453-7. [Abstract] [Full-text]
55. Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung.
    Br J Cancer, 93(4): 450-2. [Abstract] [Full-text]
56. The utility of B72.3, carcinoembryonic antigen, and Leu M-1 in cell blocks: an adjunct to fine-needle aspiration diagnosis of bronchioloalveolar carcinoma of the lung.
    Cancer, 105(4): 246-52. [Abstract] [Full-text]
57. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
    Cancer Gene Ther, 12(9): 737-48. [Abstract] [Full-text]
58. Quantitative analysis of lung and tumour mobility: comparison of two time-resolved MRI sequences.
    Br J Radiol, 78(933): 836-40. [Abstract] [Full-text]
59. Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
    J Clin Oncol, 23(24): 5774-8. [Abstract] [Full-text]
60. Regression of pulmonary MALT lymphoma after treatment with rituximab.
    Leuk Lymphoma, 46(9): 1383-6. [Abstract] [Full-text]
61. Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide.
    Leuk Lymphoma, 46(9): 1379-82. [Abstract] [Full-text]
62. Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer.
    Oncogene, 24(35): 5502-9. [Abstract] [Full-text]
63. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Cancer Lett, 227(2): 133-9. [Abstract] [Full-text]
64. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer.
    Int J Radiat Oncol Biol Phys, 63(1): 253-60. [Abstract] [Full-text]
65. Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.
    Int J Radiat Oncol Biol Phys, 63(1): 179-87. [Abstract] [Full-text]
66. The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system.
    Int J Radiat Oncol Biol Phys, 63(1): 164-9. [Abstract] [Full-text]
67. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
    Int J Radiat Oncol Biol Phys, 63(1): 5-24. [Abstract] [Full-text]
68. Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.
    Tumour Biol, 26(4): 195-200. [Abstract] [Full-text]
69. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer.
    JAMA, 294(8): 931-6. [Abstract] [Full-text]
70. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Radiology, 236(3): 1011-9. [Abstract] [Full-text]
71. The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.
    FEBS Lett, 579(21): 4635-41. [Abstract] [Full-text]
72. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.
    Int J Cancer, 117(2): 294-9. [Abstract] [Full-text]
73. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
    Int J Cancer, 117(2): 241-7. [Abstract] [Full-text]
74. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
    Lancet Oncol, 6(9): 669-77. [Abstract] [Full-text]
75. Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy.
    J Surg Oncol, 91(4): 237-42. [Abstract] [Full-text]
76. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.
    Clin Exp Metastasis, 22(1): 69-76. [Abstract] [Full-text]
77. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium.
    Clin Exp Metastasis, 22(1): 11-24. [Abstract] [Full-text]
78. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
    Proc Natl Acad Sci U S A, 102(35): 12507-12. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.